The Falkor reference sent me to google. I'm a harsh critic of Linda, but that is over the top.
Forbes has generally been supportive, publishing some fairly obvious PUMP pieces on its website, so this is a departure.
Nothing imminent. Technically possible, but unlikely. Exchange rules about low price are ignored for long periods.
For a biotech example, PVCT has been under $1 for over a year without delisting or reverse split.
Georgie is a PUMPER. It appears that folks already know his work on AVXL. He'll pretend to play nice, but occasionally unleash a very un-Christian string of insults.
Since you are either too lazy to do minimal work, or just need to be spoon fed... The combined holdings of Vanguard, BlackRock, and State Street are roughly 5m shares.
Now do you get it?
Indexing is another part of investing where your knowledge is lacking.
Look up the nwbo holdings for Vanguard, Blackrock (Ishares), and State Street. You will find that the vast majority are in index funds or ETFs tied to Russell Indexes.
The Russell Indexes are reconstituted once per year. The ranking day for 2016 is May 27th. The changes are effective at the end of June. All those index fund shares will be sold because nwbo drops out of the index.
There's about 1.4m Series B warrants still out there. You should do the basic algebra before incorrectly criticizing.
10 days of incremental sell volume doesn't matter to you? Whatever.
The Cognate MFN issue blocks nwbo from resolving the Nasdaq issue. They can't publish their whitewash investigation without resolving the Nasdaq issue. I seriously doubt that any real institutional investment or pharma partnership can happen without resolution of the Nasdaq issue and investigation. What part of that do you not understand?
If you don't think running out of cash matters, then you are so naive as to be beyond anyone's ability to help.
Here are 4 issues to consider before anything on your list applies.
1) 5/23 expiration of balance of overallotment.
2) 5/27 Russell Reconstitution ranking day. At least 5m share overhang on market through end of June.
3) Potentially running out of cash, not because of debt overhang, but basic monthly expenses.
4) Resolving Cognate MFN issue. Required for your #3, which has to precede 1,2,5.
And one issue slightly further out from 10-Q that no one seems to have noticed
"$4.7 million of the mortgage loans are due in August 2016 and the remainder in November 2016."
The remainder referred to is 6.6m. I'd expect the mortgages to be tough to refinance without resolving the environmental issues.
You never answered my question as to whether you are abeta.
Wrong. Not hindsight at all. I posted that Linda should be raising money back when nwbo was 10+. Look it up.
Most of the longs claim to "believe in the science", despite having none of the medical research background necessary to understand it. So it's more appropriate to apply "stupid and ignorant" to your own investment in nwbo rather than anything I said.
I've never met Linda, and have no personal or professional connection.
I've posted before about reporting the Cognate structure to the SEC as a possible fraud against nwbo investors. Subsequent events have greatly strengthened that opinion. That is the reason for my low regard for Linda Powers.
Bob, most of that is silly.
I hate cancer as much as anyone, but I give zero credence to anyone claiming that is the reason for investing in nwbo. Why not any othe cancer stock? Why not American Cancer Society?
Mixing your charity and investments is the way to do both poorly.
The saddest part is that longs had the big payday in hand last summer courtesy of Woodford pushing the price to double digits.
A lot of folks let their greed blind them to the selling opportunity. Of course Linda Powers missed the same opportunity to shovel stock out the door and have multiple years of cash on hand.
Q1 ending cash 11.7m
just raised about 4m (4.2m gross - expenses)
Q1 burn rate was about 6m per month.
Assuming that the burn rate is unchanged, my estimate for cash right now is roughly 6.7m. That's not enough to get through the rest of Q2 unless they raise more cash or cut expenses.
Frank, you know the pattern. Every conference gets PUMPED, then nothing happens. Same story every time.
All the penny stock nonsense is posted by spambots. There is no one out there to read your response.
Q: Why did the medical lab start using lawyers for testing instead of rats?
A: There were some things the rats just wouldn't do, plus the lab techs kept getting attached to the rats.
Are you abeta? Same habit of endlessly repeating something like "fair value of billions".
Repetition does not make a baseless claim become truth.
This looks like a modification to the terms of the extension of the March deal. It covers 4.4m out of 5.8m (roughly 76%) of the Series B warrants. It appears to be a done deal as of yesterday.
I did not see anything that further modifies the terms and extension currently set to expire 5/23.
Unclear if the same terms were offered to all holders Series B warrants. Seems likely. If so, either some did not accept or they are still negotiating.